Literature DB >> 19319023

Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections.

Maria R Moro1, Cynthia A Bonville, Manika Suryadevara, Erin Cummings, Diala Faddoul, Hazar Kobayaa, Patrick J Branigan, Joseph B Domachowske.   

Abstract

BACKGROUND: Adenovirus infection manifests in many ways, with respiratory and gastrointestinal symptoms predominating.
METHODS: We performed a retrospective chart review on children evaluated at our center who had a nasal wash culture positive for adenovirus. Archived nasal washes were retrieved. Polymerase chain reaction for 15 respiratory viruses was performed on these samples. Patients who were coinfected with another virus were excluded. Adenovirus typing was performed using polymerase chain reaction primers directed at the conserved hexon gene. Bead proteomics was used to measure concentrations of inflammatory mediators.
RESULTS: Seventy-eight patients were infected only with adenovirus. The clinical diagnosis was upper respiratory infection in 60%, pneumonia in 18%, febrile seizure in 8%, and bronchiolitis in 6%. Subgroup-C and B1 infections were most common. Seventy percent of patients with upper respiratory infection and all 5 patients with bronchiolitis had a subgroup-C infection; pneumonia was caused by subgroup-B1 and C viruses. Compared with asymptomatic control patients, adenovirus infected patients had higher nasal wash concentrations of interleukin (IL)-1alpha, IL-6, inducible protein-10, macrophage inflammatory protein-1alpha, tumor necrosis factor alpha, monokine induced by gamma interferon, and interferon-alpha (P < 0.05). In addition, we found that IL-8 and IL-1alpha (P < 0.05) were higher in the nasal washes obtained from hospitalized patients than in nonhospitalized patients.
CONCLUSIONS: Adenovirus infection causes an array of clinical disease and is associated with local production of several proinflammatory cytokines. The observation that nasal wash IL-8 and IL-1alpha concentrations were higher in patients requiring hospitalization suggests that these mediators contribute to disease severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319023     DOI: 10.1097/INF.0b013e31819075a6

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  26 in total

1.  Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.

Authors:  T Wang; E B Ahmed; L Chen; J Xu; J Tao; C-R Wang; M-L Alegre; A S Chong
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Clinical trial report: viral coinfections with invasive pneumococcal disease.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

3.  Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Authors:  Christy M Tabarani; Cynthia A Bonville; Manika Suryadevara; Patrick Branigan; Dongliang Wang; Danning Huang; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

Review 4.  Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets.

Authors:  Christie M Sayes; Herman Staats; Anthony J Hickey
Journal:  Pharm Res       Date:  2014-06-12       Impact factor: 4.200

5.  Adenovirus E1B 19-kilodalton protein modulates innate immunity through apoptotic mimicry.

Authors:  Jay R Radke; Fernando Grigera; David S Ucker; James L Cook
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

6.  Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain.

Authors:  Helena Rebelo-de-Andrade; Cristiana Pereira; Marta Gíria; Ema Prudêncio; Maria João Brito; Etelvina Calé; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

7.  Local production of inflammatory mediators during childhood parainfluenza virus infection.

Authors:  Rana E El Feghaly; Lindsay McGann; Cynthia A Bonville; Patrick J Branigan; Manika Suryadevera; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

8.  Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study.

Authors:  M A Sabin; D Burgner; R L Atkinson; Z Pei-Lun Lee; C G Magnussen; M Cheung; M Kähönen; T Lehtimäki; E Jokinen; T Laitinen; N Hutri-Kähönen; J S A Viikari; M Juonala; O T Raitakari
Journal:  Int J Obes (Lond)       Date:  2015-06-09       Impact factor: 5.095

9.  Epidemiology of severe pediatric adenovirus lower respiratory tract infections in Manitoba, Canada, 1991-2005.

Authors:  Saleh Alharbi; Paul Van Caeseele; Raquel Consunji-Araneta; Taoufik Zoubeidi; Sergio Fanella; Abdul-Kader Souid; Ahmed R Alsuwaidi
Journal:  BMC Infect Dis       Date:  2012-03-13       Impact factor: 3.090

Review 10.  The challenge for gene therapy: innate immune response to adenoviruses.

Authors:  Bart Thaci; Ilya V Ulasov; Derek A Wainwright; Maciej S Lesniak
Journal:  Oncotarget       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.